Stereotaxis (STXS) EBITDA (2010 - 2026)

Stereotaxis (STXS) has 17 years of EBITDA data on file, last reported at -$6.0 million in Q1 2026.

• On a quarterly basis, EBITDA fell 0.88% year-over-year to -$6.0 million in Q1 2026; TTM through Mar 2026 was -$22.2 million, a 14.5% increase from a year earlier, with the FY2025 full-year figure at -$22.1 million, up 10.62% from the prior year.
• EBITDA for Q1 2026 stood at -$6.0 million, down from -$5.6 million in the prior quarter.
• Over the last five years, EBITDA for STXS reached as high as -$4.0 million in Q2 2025 and fell as low as -$7.6 million in Q4 2024.
• Historically, EBITDA has averaged -$5.5 million across 5 years, with a median of -$5.6 million in 2023.
• Across the five-year window, EBITDA sank 167.6% in 2022 and soared 33.95% in 2025, its largest moves.
• Year by year, EBITDA stood at -$4.5 million in 2022, then slipped by 19.03% to -$5.3 million in 2023, then plunged by 43.8% to -$7.6 million in 2024, then rose by 25.93% to -$5.6 million in 2025, then fell by 5.88% to -$6.0 million in 2026.
• Per Business Quant data, the three most recent EBITDA figures were -$6.0 million in Q1 2026, -$5.6 million in Q4 2025, and -$6.6 million in Q3 2025.